Skip to content

Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence

Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02534142
Enrollment
774
Registered
2015-08-27
Start date
2015-10-31
Completion date
2017-12-20
Last updated
2018-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

Approximately 40% of members with a positive fecal occult blood result do not continue to followup colonoscopy in Meuhedet. The purpose of this study is to identify the structural, process, carer and patient related causes of undertreatment and suggest appropriate organisational interventions. Using both quantitative and qualitative methods, the investigators will identify organisational and personal barriers to completion of followup of positive FOBT.

Detailed description

Colorectal cancer is the second in incidence and mortality among malignant tumors. Early detection of the disease is an effective means of reducing mortality and is possible through a fecal occult blood test. In the case of a positive result colonoscopy is required. In Israel, about 30% of people with a positive occult blood test do not perform a follow-up test. The aim of the study is to identify existing barriers to undergoing colonoscopy in a normal-risk population and improving adherence through different intervention mechanisms. At the end of the study we will describe effective intervention models at three levels: the patient, physicians and the organisation to improve early detection of colon cancer. Innovation of the Study * It will focus on the normal-risk population groups in Israel with a positive occult blood that didn't undergo colonoscopy. * Will identify the barriers in diverse populations * Will review the accessibility of diagnostic facilities forcolon cancer in Israel. * Will propose intervention programs to improve adherence at all levels in the process. Study Methods: A prospective study sing both both quantitative and qualitative methods in Meuhedet Health Services Target Population: Health system managers, physicians, and patients (a representative sample of 200 patients adhere colonoscopy and 600 that didn't adhere). Data collection databases from Meuhedet. The study will include questionnaires, focus groups and interviews. Stages of the study: 1. Describe the magnitude of the problem 2. Map the barriers to adherence with colonoscopy recommendations among patients, physicians and geographic availability of colonoscopies facilities. 3. Suggest intervention models for physicians, patients and organisations according to the information provided by data collection. 4. Recommendation to decision makers on the implementation of national policy intervention. Data processing: will use SPSS statistical analysis with the types of variables.

Interventions

None listed

Sponsors

Bar-Ilan University, Israel
CollaboratorOTHER
Meuhedet. Healthcare Organization
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
51 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

Members of MHC aged 50-74 who completed a fecal occult blood test during the study period.

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frameDescription
Variables related to non-completion of colonoscopy following a positive fecal occult blood test18 monthsQuantitative and qualitative variables associated with non-completion of colonoscopical followup among members with a positive screening fecal occult test result: Availability and distance variables (hours, kms), Patient knowledge and awareness (questionnaire scores), Physician knowledge and awareness (qualitative data),

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026